Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Dental Research Effort Aims to Stem Oral Cancer in India

By LabMedica International staff writers
Posted on 23 Sep 2015
Pioneering use of laser technology to advance better methods of tracking and treating oral cancers (OCs) is leading to the ability to noninvasively detect these cancers with a portable device.

Regular biopsies were standard practice to monitor precancerous mouth lesions before they may metastasized. More...
But often patients did not return after the first biopsy due to the pain. Petra Wilder-Smith, DDS, PhD, professor-in-residence and director of the dental program at the Beckman Laser Institute & Medical Clinic, University of California, Irvine (Irvine, CA, USA) and M.A. Kuriakose, chief of head and neck oncology at the Mazumdar-Shaw Cancer Center (Bangalore, India) have partnered in leading teams to develop and test a low-cost, portable screening device that field-workers in India can use to detect possible OC. The device is solar-powered, slightly larger than a shoebox, and can take laser images of oral lesions that will be sent via mobile phone to Mazumdar-Shaw and Beckman Laser Institute for assessment. The technology could enable people—many of whom rarely see dentists—to receive early-stage care and dramatically improve their outcomes.

“Petra is widely recognized for her visionary leadership in the pioneering use of optics and photonics technologies for improving oral health,” said Bruce Tromberg, director of the Beckman Laser Institute, “She has a special combination of abilities as a compassionate clinician with a unique understanding of patient needs, particularly in medically underserved communities.”

OCs are caused by a variety of factors, including tobacco and alcohol use, HPV infections, poor diets, and the chewing of betel quid, which is common in many parts of Asia. Most OC patients first see a doctor at late stages where survival rates are under 40%. In low-resource nations like India, which has the planet’s highest burden of OC (about 80,000 new cases annually), the situation is more acute, primarily due to lack of awareness and healthcare access. Data from the Million Death Study show that OC accounts for 35% of all cancer deaths among Indian men.

The study is in its first phase. Teams from Beckman and Mazumdar-Shaw have traveled India gauging mobile phone reception, and a prototype of the device has been tested on a small group of patients. They are gearing up for testing a larger cohort of subjects across India.

“We’re in the process of reviewing the data now to figure out where we draw the lines that determine whether a measurement signifies that the tissues are normal or precancerous or malignant,” said Dr. Wilder-Smith, “We’re really satisfied with the progress.” With another collaborator at the University of Arizona, she is creating a snap-on laser device for smartphones that can also perform lesion analysis in the field. The technology is in its experimental phase, and the researchers are seeking funding to support further development. “We are truly advancing methods to remotely use laser technology to diagnose tissues, which can help out both patients and oncologists,” she said.

Related Links:

Beckman Laser Institute & Medical Clinic, U California, Irvine
Mazumdar-Shaw Cancer Center



New
Gold Member
Hybrid Pipette
SWITCH
Collection and Transport System
PurSafe Plus®
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
New
Gold Member
Automatic Hematology Analyzer
DH-800 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.